BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15999989)

  • 1. Design and synthesis of new nonsteroidal glucocorticoid modulators through application of an "agreement docking" method.
    Barker M; Clackers M; Demaine DA; Humphreys D; Johnston MJ; Jones HT; Pacquet F; Pritchard JM; Salter M; Shanahan SE; Skone PA; Vinader VM; Uings I; McLay IM; Macdonald SJ
    J Med Chem; 2005 Jul; 48(14):4507-10. PubMed ID: 15999989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
    Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
    J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.
    Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ
    J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists.
    Yates CM; Brown PJ; Stewart EL; Patten C; Austin RJ; Holt JA; Maglich JM; Angell DC; Sasse RZ; Taylor SJ; Uings IJ; Trump RP
    J Med Chem; 2010 Jun; 53(11):4531-44. PubMed ID: 20469868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new selective glucocorticoid receptor agonist leads.
    Berger M; Rehwinkel H; Schmees N; Schäcke H; Edman K; Wissler L; Reichel A; Jaroch S
    Bioorg Med Chem Lett; 2017 Feb; 27(3):437-442. PubMed ID: 28043796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
    Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
    J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
    McMaster A; Ray DW
    Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).
    Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC
    J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of quinolines as selective glucocorticoid receptor agonists.
    Jaroch S; Berger M; Huwe C; Krolikiewicz K; Rehwinkel H; Schäcke H; Schmees N; Skuballa W
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5835-8. PubMed ID: 20727743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand.
    Betageri R; Zhang Y; Zindell RM; Kuzmich D; Kirrane TM; Bentzien J; Cardozo M; Capolino AJ; Fadra TN; Nelson RM; Paw Z; Shih DT; Shih CK; Zuvela-Jelaska L; Nabozny G; Thomson DS
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4761-9. PubMed ID: 16112571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the molecular basis of action of the passive antiglucocorticoid 21-hydroxy-6,19-epoxyprogesterone.
    Alvarez LD; Martí MA; Veleiro AS; Presman DM; Estrin DA; Pecci A; Burton G
    J Med Chem; 2008 Mar; 51(5):1352-60. PubMed ID: 18284186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
    Hudson AR; Roach SL; Higuchi RI; Phillips DP; Bissonnette RP; Lamph WW; Yen J; Li Y; Adams ME; Valdez LJ; Vassar A; Cuervo C; Kallel EA; Gharbaoui CJ; Mais DE; Miner JN; Marschke KB; Rungta D; Negro-Vilar A; Zhi L
    J Med Chem; 2007 Sep; 50(19):4699-709. PubMed ID: 17705362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel synthesis of the hexahydroimidazo[1,5b]isoquinoline scaffold: application to the synthesis of glucocorticoid receptor modulators.
    Xiao HY; Wu DR; Malley MF; Gougoutas JZ; Habte SF; Cunningham MD; Somerville JE; Dodd JH; Barrish JC; Nadler SG; Dhar TG
    J Med Chem; 2010 Feb; 53(3):1270-80. PubMed ID: 20047280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining 3D-QSAR, docking, molecular dynamics and MM/PBSA methods to predict binding modes for nonsteroidal selective modulator to glucocorticoid receptor.
    Xu Y; Zhang T; Chen M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):393-6. PubMed ID: 19081253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug insight: selective agonists and antagonists of the glucocorticoid receptor.
    McMaster A; Ray DW
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):91-101. PubMed ID: 18212811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
    Peeters BW; Ruigt GS; Craighead M; Kitchener P
    Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal progesterone receptor ligands (I): synthesis and SAR of new tetrahydronaphthofuranone derivatives.
    Shinei R; Kurihara K; Tanabe K; Tabata Y; Kurata Y; Hoshiko S; Okonogi T
    Bioorg Med Chem; 2006 Jul; 14(14):4850-61. PubMed ID: 16580213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
    Shah N; Scanlan TS
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5199-203. PubMed ID: 15380227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms for corticotropin-releasing hormone gene repression by glucocorticoid in BE(2)C neuronal cell line.
    Yamamori E; Iwasaki Y; Taguchi T; Nishiyama M; Yoshida M; Asai M; Oiso Y; Itoi K; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):142-8. PubMed ID: 17169483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.